Indoco Remedies Limited (NSE:INDOCO)

Indoco Remedies Statistics

Total Valuation

Indoco Remedies has a market cap or net worth of INR 20.21 billion. The enterprise value is 30.70 billion.

Market Cap	20.21B
Enterprise Value	30.70B

Important Dates

The last earnings date was Thursday, May 7, 2026.

Earnings Date	May 7, 2026
Ex-Dividend Date	Sep 4, 2025

Share Statistics

Indoco Remedies has 92.30 million shares outstanding. The number of shares has decreased by -3.46% in one year.

Current Share Class	92.30M
Shares Outstanding	92.30M
Shares Change (YoY)	-3.46%
Shares Change (QoQ)	-9.20%
Owned by Insiders (%)	22.34%
Owned by Institutions (%)	20.74%
Float	36.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	27.89
PS Ratio	1.09
PB Ratio	2.17
P/TBV Ratio	2.74
P/FCF Ratio	45.21
P/OCF Ratio	10.51
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.16, with an EV/FCF ratio of 68.69.

EV / Earnings	-32.27
EV / Sales	1.66
EV / EBITDA	21.16
EV / EBIT	164.36
EV / FCF	68.69

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.17.

Current Ratio	1.13
Quick Ratio	0.52
Debt / Equity	1.17
Debt / EBITDA	7.51
Debt / FCF	24.38
Interest Coverage	0.15

Financial Efficiency

Return on equity (ROE) is -10.12% and return on invested capital (ROIC) is 0.95%.

Return on Equity (ROE)	-10.12%
Return on Assets (ROA)	0.46%
Return on Invested Capital (ROIC)	0.95%
Return on Capital Employed (ROCE)	1.21%
Weighted Average Cost of Capital (WACC)	8.07%
Revenue Per Employee	3.08M
Profits Per Employee	-158,583
Employee Count	6,000
Asset Turnover	0.74
Inventory Turnover	1.31

Taxes

Income Tax	-78.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.22% in the last 52 weeks. The beta is 0.62, so Indoco Remedies's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-9.22%
50-Day Moving Average	202.31
200-Day Moving Average	247.54
Relative Strength Index (RSI)	53.53
Average Volume (20 Days)	129,172

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Indoco Remedies had revenue of INR 18.49 billion and -951.50 million in losses. Loss per share was -10.70.

Revenue	18.49B
Gross Profit	13.07B
Operating Income	186.80M
Pretax Income	-1.07B
Net Income	-951.50M
EBITDA	1.45B
EBIT	186.80M
Loss Per Share	-10.70

Balance Sheet

The company has 329.90 million in cash and 10.90 billion in debt, with a net cash position of -10.57 billion or -114.49 per share.

Cash & Cash Equivalents	329.90M
Total Debt	10.90B
Net Cash	-10.57B
Net Cash Per Share	-114.49
Equity (Book Value)	9.32B
Book Value Per Share	111.55
Working Capital	1.41B

Cash Flow

In the last 12 months, operating cash flow was 1.92 billion and capital expenditures -1.48 billion, giving a free cash flow of 447.00 million.

Operating Cash Flow	1.92B
Capital Expenditures	-1.48B
Depreciation & Amortization	1.26B
Net Borrowing	468.60M
Free Cash Flow	447.00M
FCF Per Share	4.84

Margins

Gross margin is 70.70%, with operating and profit margins of 1.01% and -5.15%.

Gross Margin	70.70%
Operating Margin	1.01%
Pretax Margin	-5.76%
Profit Margin	-5.15%
EBITDA Margin	7.85%
EBIT Margin	1.01%
FCF Margin	2.42%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.09%.

Dividend Per Share	0.20
Dividend Yield	0.09%
Dividend Growth (YoY)	-86.67%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.46%
Shareholder Yield	3.54%
Earnings Yield	-4.71%
FCF Yield	2.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 17, 2012. It was a forward split with a ratio of 7.5.

Last Split Date	May 17, 2012
Split Type	Forward
Split Ratio	7.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	6